GlassScriptPhysician profile
James R Nunley
NPI 1144227067
$2,321.77
in general payments reported to CMS, 2019-2025
19 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $129 · 2021: $611 · 2022: $335 · 2023: $390 · 2024: $342 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $939.38 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Scilex Pharmaceuticals INC. | $364.63 | 2020-2024 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $196.39 | 2020-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $196.03 | 2021-2025 | Belbuca, Xtampza |
| Relievant Medsystems, INC. | $138.55 | 2021 | |
| Curonix LLC | $65.30 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $58.91 | 2021-2023 | |
| Amgen INC. | $43.22 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $42.20 | 2021 | |
| Vertiflex, INC. | $35.86 | 2019 | |
| Nalu Medical, INC. | $33.52 | 2021 | |
| Azurity Pharmaceuticals, INC. | $33.30 | 2024 | Horizant |
| Almatica Pharma LLC | $32.03 | 2021 | |
| Pacira Therapeutics, INC. | $31.65 | 2021 | |
| Flowonix Medical Incorporated | $31.63 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sentynl Therapeutics, INC. | $29.00 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $18.37 | 2021 | |
| Depuy Synthes Sales INC. | $16.03 | 2024 | Orthovisc, Monovisc |
| Bioventus LLC | $15.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Nunley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.